Group by: Item Type | No Grouping Jump to: Article Number of items: 3. ArticleChanukuppa, V. and Paul, D. and Taunk, K. and Chatterjee, T. and Sharma, S. and Kumar, S. and Santra, M.K. and Rapole, S. (2019) XPO1 is a critical player for bortezomib resistance in multiplemyeloma: A quantitative proteomic approach. Journal of Proteomics, 209. p. 103504. Chanukuppa, V. and More, T.H. and Taunk, K. and Taware, R. and Chatterjee, T. and Sharmad, S. and Rapole, S. (2019) Serum metabolomic alterations in multiple myeloma revealed by targeted and untargeted metabolomics approaches: a pilot study. RSC Advances, 9 (51). Chanukuppa, V. and Taware, R. and Chatterjee, T. and Sharma, S. and More, T.H. and Taunk, K. and Kumar, S. and Santra, M.K. and Rapole, S. (2018) Current understanding of the potential of proteomics andmetabolomics approaches in cancer chemoresistance: A focus on Multiple Myeloma. Current Topics in Medicinal Chemistry., 18 (30). pp. 2584-2598.
|